We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
新冠候選疫苗之緊急授權: 對疫苗臨床試驗的整響.
- Authors
Singh, Jerome Amir; 著陳怡君; 編譯
- Abstract
An efficacious COVID-19 vaccine is currently the world's leading research priority. Several nations have indicated that if there is a compelling case for use of a vaccine before it is licensed, they would be prepared to authorise its emergency use or conditional approval on public health grounds. As of Dec 1, 2020, several developers of leading COVID-19 candidate vaccines have indicated that they have applied, or intend to apply, for emergency authorisation for their vaccines. Should candidate vaccines attain emergency use designation and be programmatically deployed before their phase 3 trials conclude, such a strategy could have far reaching consequences for COVID-19 vaccine research and the effective control of the COVID-19 pandemic. These issues merit careful consideration.
- Subjects
CLINICAL trials; COVID-19 vaccines; VACCINE effectiveness; COVID-19 pandemic; VACCINE trials
- Publication
Angle Health Law Review, 2022, Issue 70, p47
- ISSN
2415-5306
- Publication type
Article
- DOI
10.53106/241553062022080070005